Boston-based PathAI, a provider of AI-powered research tools and services for pathology, has raised $75 million in Series B funding. The investors include Merck Global Health Innovation Fund and Bristol-Myers Squibb.
Source: Press Release
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
